# AbbVie Ventures

Source: https://onco.cc/companies/abbvie-ventures/  
OnCo record `abbvie-ventures` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

AbbVie's corporate venture arm, which invests in early-stage biotech companies in AbbVie's therapeutic areas including cancer. Its web pages blocked automated access at the time of research.

## Summary

AbbVie Ventures is the corporate venture capital group of AbbVie, the North Chicago-based pharmaceutical company, and invests strategically in early-stage companies developing new therapeutics and platforms in AbbVie's areas of interest, which include oncology, immunology and neuroscience. Both the AbbVie Ventures overview and portfolio pages on abbvie.com returned HTTP 403 (Cloudflare) on every attempt with two different fetch methods, so the firm's own description, founding year, strategy and named oncology portfolio companies could not be confirmed from a primary source.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: corporate-venture
- HQ: North Chicago, IL
- Type: investor
- Website: https://www.abbvie.com/partnerships/abbvie-ventures.html

## Notes

- Website could not be fetched by the research pass on 2026-09-10 (bot protection, JavaScript-only or parked domain); location and description rest on the firm's public materials and on press releases that name it. abbvie.com returned 403 from both curl and WebFetch. Headquarters follows AbbVie's corporate base.

## Sources

- Official website: https://www.abbvie.com/partnerships/abbvie-ventures.html

## Connected records

- companies: [AbbVie (incl. ImmunoGen, Capstan)](https://onco.cc/companies/abbvie/)

---
JSON: https://onco.cc/api/v1/entities/abbvie-ventures.json